FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KCNN3-YEATS4

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KCNN3-YEATS4
FusionPDB ID: 41530
FusionGDB2.0 ID: 41530
HgeneTgene
Gene symbol

KCNN3

YEATS4

Gene ID

3782

8089

Gene namepotassium calcium-activated channel subfamily N member 3YEATS domain containing 4
SynonymsKCa2.3|SK3|SKCA3|ZLS3|hSK34930573H17Rik|B230215M10Rik|GAS41|NUBI-1|YAF9
Cytomap

1q21.3

12q15

Type of geneprotein-codingprotein-coding
Descriptionsmall conductance calcium-activated potassium channel protein 3SKCa 3potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3potassium intermediate/small conductance calcium-activated channel, subfamily N, member YEATS domain-containing protein 4NuMA binding protein 1glioma-amplified sequence 41nuBI1
Modification date2020032920200313
UniProtAcc

Q9UGI6

Main function of 5'-partner protein: FUNCTION: Forms a voltage-independent potassium channel activated by intracellular calcium (PubMed:31155282). Activation is followed by membrane hyperpolarization. Thought to regulate neuronal excitability by contributing to the slow component of synaptic afterhyperpolarization. The channel is blocked by apamin. {ECO:0000269|PubMed:31155282}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000358505, ENST00000271915, 
ENST00000361147, ENST00000515643, 
ENST00000247843, ENST00000548020, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 6 X 5=18010 X 4 X 4=160
# samples 810
** MAII scorelog2(8/180*10)=-1.16992500144231
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(10/160*10)=-0.678071905112638
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KCNN3 [Title/Abstract] AND YEATS4 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KCNN3 [Title/Abstract] AND YEATS4 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KCNN3(154705479)-YEATS4(69756568), # samples:3
Anticipated loss of major functional domain due to fusion event.KCNN3-YEATS4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNN3-YEATS4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNN3-YEATS4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNN3-YEATS4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNN3-YEATS4 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
KCNN3-YEATS4 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF.
KCNN3-YEATS4 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneYEATS4

GO:0043967

histone H4 acetylation

14966270

TgeneYEATS4

GO:0043968

histone H2A acetylation

14966270



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:154705479/chr12:69756568)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KCNN3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across YEATS4 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000271915KCNN3chr1154705479-ENST00000247843YEATS4chr1269756568+30191906582538826
ENST00000271915KCNN3chr1154705479-ENST00000548020YEATS4chr1269756568+26921906582376772
ENST00000361147KCNN3chr1154705479-ENST00000247843YEATS4chr1269756568+19198061311438435
ENST00000361147KCNN3chr1154705479-ENST00000548020YEATS4chr1269756568+15928061311276381
ENST00000271915KCNN3chr1154705478-ENST00000247843YEATS4chr1269756567+30191906582538826
ENST00000271915KCNN3chr1154705478-ENST00000548020YEATS4chr1269756567+26921906582376772
ENST00000361147KCNN3chr1154705478-ENST00000247843YEATS4chr1269756567+19198061311438435
ENST00000361147KCNN3chr1154705478-ENST00000548020YEATS4chr1269756567+15928061311276381

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000271915ENST00000247843KCNN3chr1154705479-YEATS4chr1269756568+0.0108946990.9891053
ENST00000271915ENST00000548020KCNN3chr1154705479-YEATS4chr1269756568+0.0301572550.96984273
ENST00000361147ENST00000247843KCNN3chr1154705479-YEATS4chr1269756568+0.0002046940.9997954
ENST00000361147ENST00000548020KCNN3chr1154705479-YEATS4chr1269756568+0.0003718860.99962807
ENST00000271915ENST00000247843KCNN3chr1154705478-YEATS4chr1269756567+0.0108946990.9891053
ENST00000271915ENST00000548020KCNN3chr1154705478-YEATS4chr1269756567+0.0301572550.96984273
ENST00000361147ENST00000247843KCNN3chr1154705478-YEATS4chr1269756567+0.0002046940.9997954
ENST00000361147ENST00000548020KCNN3chr1154705478-YEATS4chr1269756567+0.0003718860.99962807

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KCNN3-YEATS4

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KCNN3chr1154705478YEATS4chr12697565671906616YCGKGVCLLTGIMGVTIVKPIVYGNV
KCNN3chr1154705478YEATS4chr1269756567806225YCGKGVCLLTGIMGVTIVKPIVYGNV
KCNN3chr1154705479YEATS4chr12697565681906616YCGKGVCLLTGIMGVTIVKPIVYGNV
KCNN3chr1154705479YEATS4chr1269756568806225YCGKGVCLLTGIMGVTIVKPIVYGNV

Top

Potential FusionNeoAntigen Information of KCNN3-YEATS4 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KCNN3-YEATS4_154705478_69756567.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:22CLLTGIMGV0.99470.8356615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:27CLLTGIMGV0.99270.8706615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:13CLLTGIMGV0.99180.9093615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:16CLLTGIMGV0.99170.8476615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:11CLLTGIMGV0.99140.8447615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:24CLLTGIMGV0.99040.8423615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:30CLLTGIMGV0.99040.8423615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:67CLLTGIMGV0.99040.8423615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:60CLLTGIMGV0.99020.8298615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:21CLLTGIMGV0.990.8799615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:38CLLTGIMGV0.97950.8758615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:19CLLTGIMGV0.97890.7936615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:35CLLTGIMGV0.97260.8493615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:29CLLTGIMGV0.970.8434615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:04CLLTGIMGV0.96480.8413615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:20CLLTGIMGV0.95510.8465615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A30:08GIMGVTIVK0.93660.62211019
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:17CLLTGIMGV0.89960.8123615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:60VCLLTGIMGV0.93360.8362515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:24VCLLTGIMGV0.93130.8655515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:67VCLLTGIMGV0.93130.8655515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:30VCLLTGIMGV0.93130.8655515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:16VCLLTGIMGV0.92090.842515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:29VCLLTGIMGV0.85820.8658515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:35VCLLTGIMGV0.84570.8734515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:20VCLLTGIMGV0.83960.8683515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:16GVCLLTGIMGV0.92390.6638415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:60GVCLLTGIMGV0.90570.785415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:30GVCLLTGIMGV0.90410.7828415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:24GVCLLTGIMGV0.90410.7828415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:67GVCLLTGIMGV0.90410.7828415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:35GVCLLTGIMGV0.86910.7908415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:29GVCLLTGIMGV0.84210.7858415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:01CLLTGIMGV0.99040.8423615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:01VCLLTGIMGV0.93130.8655515
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:01GVCLLTGIMGV0.90410.7828415
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:03CLLTGIMGV0.99560.9123615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A02:06CLLTGIMGV0.990.8799615
KCNN3-YEATS4chr1154705478chr12697565671906HLA-A30:01GIMGVTIVK0.92860.77911019

Top

Potential FusionNeoAntigen Information of KCNN3-YEATS4 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KCNN3-YEATS4_154705478_69756567.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1201GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1201IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1201TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1203GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1203IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1203TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1205GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1205IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1205TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1206GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1206IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1206TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1207GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1207IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1207TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1208GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1208IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1208TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1210GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1210IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1210TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1211GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1211IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1211TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1212GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1212IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1212TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1213GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1213IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1214GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1214IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1214TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1215GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1215IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1217GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1217IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1217TGIMGVTIVKPIVYG924
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1218GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1218IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1219GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1219IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1221GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1222IMGVTIVKPIVYGNV1126
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1222GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1223GIMGVTIVKPIVYGN1025
KCNN3-YEATS4chr1154705478chr12697565671906DRB1-1223IMGVTIVKPIVYGNV1126

Top

Fusion breakpoint peptide structures of KCNN3-YEATS4

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
867CLLTGIMGVTIVKPKCNN3YEATS4chr1154705478chr12697565671906

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KCNN3-YEATS4

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN867CLLTGIMGVTIVKP-6.33173-6.44513
HLA-B14:023BVN867CLLTGIMGVTIVKP-1.81046-2.84576
HLA-B52:013W39867CLLTGIMGVTIVKP-5.92784-6.04124
HLA-B52:013W39867CLLTGIMGVTIVKP-4.3074-5.3427
HLA-A24:025HGA867CLLTGIMGVTIVKP-6.68795-7.72325
HLA-A24:025HGA867CLLTGIMGVTIVKP-5.73606-5.84946
HLA-B44:053DX8867CLLTGIMGVTIVKP-6.99493-8.03023
HLA-B44:053DX8867CLLTGIMGVTIVKP-6.82556-6.93896
HLA-A02:016TDR867CLLTGIMGVTIVKP-4.47214-5.50744

Top

Vaccine Design for the FusionNeoAntigens of KCNN3-YEATS4

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KCNN3-YEATS4chr1154705478chr12697565671019GIMGVTIVKGGCATCATGGGTGTTACTATCGTTAAA
KCNN3-YEATS4chr1154705478chr1269756567415GVCLLTGIMGVGGTGTCTGTCTCCTCACTGGCATCATGGGTGTT
KCNN3-YEATS4chr1154705478chr1269756567515VCLLTGIMGVGTCTGTCTCCTCACTGGCATCATGGGTGTT
KCNN3-YEATS4chr1154705478chr1269756567615CLLTGIMGVTGTCTCCTCACTGGCATCATGGGTGTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KCNN3-YEATS4chr1154705478chr12697565671025GIMGVTIVKPIVYGNGGCATCATGGGTGTTACTATCGTTAAACCAATAGTTTACGGTAAT
KCNN3-YEATS4chr1154705478chr12697565671126IMGVTIVKPIVYGNVATCATGGGTGTTACTATCGTTAAACCAATAGTTTACGGTAATGTT
KCNN3-YEATS4chr1154705478chr1269756567924TGIMGVTIVKPIVYGACTGGCATCATGGGTGTTACTATCGTTAAACCAATAGTTTACGGT

Top

Information of the samples that have these potential fusion neoantigens of KCNN3-YEATS4

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCKCNN3-YEATS4chr1154705478ENST00000271915chr1269756567ENST00000247843TCGA-FX-A2QS

Top

Potential target of CAR-T therapy development for KCNN3-YEATS4

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to KCNN3-YEATS4

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KCNN3-YEATS4

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource